header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-6877
Fish name: rps7hi1034bTg/hi1034bTg
Genotype: rps7hi1034bTg/hi1034bTg
Targeting Reagent: none
HUMAN DISEASE MODELED by rps7hi1034bTg/hi1034bTg
No data available
GENE EXPRESSION
Gene expression in rps7hi1034bTg/hi1034bTg
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab6-rps6k chemical treatment: Trolox Fig. 7 with image from Heijnen et al., 2014
Ab6-rps6k control Fig. 4 with imageFig. 7 with image from Heijnen et al., 2014
Ab1-rps7 rps7 control Fig. 3 with image from Heijnen et al., 2014
Reporter gene expression No data available
PHENOTYPE
Phenotype in rps7hi1034bTg/hi1034bTg
Phenotype Conditions Figures
apoptotic process increased process quality, abnormal control Fig. 1 from Antunes et al., 2015
brain apoptotic process increased process quality, abnormal control Fig. 1 from Antunes et al., 2015
brain cell death increased process quality, abnormal radiation Fig. 2 from Antunes et al., 2015
caudal fin apoptotic process increased process quality, abnormal control Fig. 1 from Antunes et al., 2015
caudal fin cell death increased process quality, abnormal radiation Fig. 2 from Antunes et al., 2015
cell death increased process quality, abnormal radiation Fig. 2 from Antunes et al., 2015
embryonic hemopoiesis decreased process quality, abnormal control Fig. 3 with image from Heijnen et al., 2014
eye decreased size, abnormal standard conditions Fig. S3 with image from Heijnen et al., 2014
fourth ventricle edematous, abnormal standard conditions Fig. S3 with image from Heijnen et al., 2014
head decreased size, abnormal standard conditions Fig. S3 with image from Heijnen et al., 2014
heart edematous, abnormal standard conditions Fig. S3 with image from Heijnen et al., 2014
hemopoiesis decreased process quality, abnormal control Fig. 1 from Antunes et al., 2015
hindbrain inflated, abnormal standard conditions Fig. S2 from Antunes et al., 2015
nucleate erythrocyte decreased amount, abnormal control Fig. 1 from Antunes et al., 2015
nucleate erythrocyte has extra parts of type nucleate erythrocyte autolysosome, abnormal control Fig. 3 with image from Heijnen et al., 2014
nucleate erythrocyte has extra parts of type nucleate erythrocyte autophagosome, abnormal control Fig. 3 with image from Heijnen et al., 2014
nucleate erythrocyte autophagy increased occurrence, abnormal control Fig. 3 with image from Heijnen et al., 2014
pericardium edematous, abnormal standard conditions Fig. S2 from Antunes et al., 2015
protein kinase B signaling decreased occurrence, abnormal control Fig. 5 with image from Heijnen et al., 2014
ribosomal protein S6 kinase activity increased occurrence, abnormal control Fig. 4 with image from Heijnen et al., 2014
whole organism has fewer parts of type nucleate erythrocyte, abnormal control Fig. 3 with image from Heijnen et al., 2014
whole organism semi-viable, abnormal chemical treatment: Trolox Fig. S3 with image from Heijnen et al., 2014
whole organism semi-viable, abnormal chemical treatment: Trolox Fig. 7 with image from Heijnen et al., 2014
whole organism semi-viable, abnormal standard conditions Fig. S3 with image from Heijnen et al., 2014
whole organism autophagy increased occurrence, abnormal control Fig. 3 with image from Heijnen et al., 2014
whole organism Golgi apparatus morphology, abnormal control Fig. 3 with image from Heijnen et al., 2014
whole organism mitochondrion morphology, abnormal control Fig. 3 with image from Heijnen et al., 2014

CITATIONS  (4)